Pål Andre Holme

5PUBLICATIONS
8CO-AUTHORS
Epidemiological modellingHaematologyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 17, 2024
Safety and efficacy of damoctocog alfa pegol prophylaxis in patients with severe haemophilia A: Results of an interventional, post-marketing study.

Pål André Holme, Lone Hvitfeldt Poulsen, Claudia Tueckmantel

|Jun 02, 2020
Management of comorbidities in haemophilia.

Christine L Kempton, Michael Makris, Pål Andre Holme

|Jul 12, 2019
Fixed doses of N8-GP prophylaxis maintain moderate-to-mild factor VIII levels in the majority of patients with severe hemophilia A.

Pratima Chowdary, Manuel Carcao, Pål A Holme

|Nov 06, 2018
Continuous infusion of simoctocog alfa in haemophilia A patients undergoing surgeries.

Pål Andre Holme, Geir E Tjønnfjord

|Sep 06, 2017
Continuous infusion of coagulation factor concentrates during intensive treatment.

P A Holme, G E Tjønnfjord, A Batorova

Pageof 1